Transparency Data Regulations and Impact on Pharmacovigilance Communication

被引：0
|
作者：
Tomczyk, S.
机构：
来源：
DRUG SAFETY | 2013年 / 36卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：919 / 920
页数：2
相关论文
共 50 条
  • [1] Data Quality and Methodological Transparency in Pharmacovigilance
    Boehm, R.
    Eggeling, C.
    Polomski, T.
    Heidebrecht, D.
    von Hehn, L.
    Herdegen, T.
    Klein, H-J
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2015, 388 : S58 - S58
  • [2] How the Transparency Data Regulations are Changing the Communication Regarding Benefit-Risk of Medications
    Tomczyk, S. T.
    [J]. DRUG SAFETY, 2014, 37 (10) : 883 - 883
  • [3] How the Transparency Data Regulations Are Changing the Communication Regarding Benefit-Risk of Medications
    Tomczyk, Sylvie
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 234 - 235
  • [4] Transparency in pharmacovigilance
    van Grootheest, AC
    Kabel, JS
    van Puijenbroek, E
    [J]. DRUG SAFETY, 2005, 28 (10) : 936 - 936
  • [5] Impact of Regulations on Transparency of Spa & Wellness Market in Poland
    Mroczek-Czetwertynska, Agnieszka
    Czetwertynski, Slawomir
    [J]. OECONOMIA COPERNICANA, 2013, 4 (04) : 91 - 102
  • [6] Impact of Risk Communication on the Number of Pharmacovigilance ICSRs in Brazil
    Capucho, H.
    Rodrigues, J. S.
    Silva, A. S. d. N.
    Cardoso, A. C. S.
    Araujo, A. C. F. d. O. G. d.
    Cruz, F. M.
    Gasparotto, F. S.
    Siqueira, H. N.
    Vidal, J. S.
    Fleck, K.
    Silva, L. A. M. d.
    Ribeiro, L. B.
    Araujo, N. G. A.
    Andrade, P. A. d. A.
    Jube, T. A.
    [J]. DRUG SAFETY, 2022, 45 (10) : 1220 - 1221
  • [7] Regulations concerning data transparency-a comparison between the USA and Europe
    Quack, Christian
    [J]. ZEITSCHRIFT FUR EVIDENZ FORTBILDUNG UND QUALITAET IM GESUNDHEITSWESEN, 2011, 105 (03): : 183 - 188
  • [8] Does risk communication have a direct impact in the overall pharmacovigilance activities?
    Arriegas, M.
    Bragança, F.
    Carmona, R.
    Pêgo, A.
    Roque, P.
    Silva, J.
    Sobral, I.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S13 - S14
  • [9] China pharmacovigilance under reformed drug regulations
    Zhang, Li
    Song, Haibo
    He, Ying
    Cong, Jialin
    Huang, Jukai
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 533 - 533
  • [10] The impact of open government data on accountability and transparency
    Saxena, Stuti
    Muhammad, Irfan
    [J]. JOURNAL OF ECONOMIC AND ADMINISTRATIVE SCIENCES, 2018, 34 (03) : 204 - 216
12345